This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2007 Jun;45(6):487-523.

doi: 10.1055/s-2007-963224.

[S3-Guidelines "Exocrine pancreatic cancer" 2007]

[Article in German]

Affiliations

PMID: 17607616
DOI: 10.1055/s-2007-963224

Practice Guideline

[S3-Guidelines "Exocrine pancreatic cancer" 2007]

[Article in German]

G Adler et al. Z Gastroenterol. 2007 Jun.

. 2007 Jun;45(6):487-523.

doi: 10.1055/s-2007-963224.

Affiliation

¹ Klinik für Innere Medizin I, Universitätsklinikum Ulm, Ulm. guido.adler@uniklinik-ulm.de

PMID: 17607616
DOI: 10.1055/s-2007-963224

No abstract available

PubMed Disclaimer

Similar articles

[Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies].
Adler G, Seufferlein T, Bischoff SC, Brambs HJ, Feuerbach S, Grabenbauer G, Hahn S, Heinemann V, Hohenberger W, Langrehr JM, Lutz MP, Micke O, Neuhaus H, Neuhaus P, Oettle H, Schlag PM, Schmid R, Schmiegel W, Schlottmann K, Werner J, Wiedenmann B, Kopp I. Adler G, et al. Dtsch Med Wochenschr. 2007 Aug;132(33):1696-700. doi: 10.1055/s-2007-984952. Dtsch Med Wochenschr. 2007. PMID: 17713866 Review. German. No abstract available.
Pancreatic adenocarcinoma.
Bond-Smith G, Banga N, Hammond TM, Imber CJ. Bond-Smith G, et al. BMJ. 2012 May 16;344:e2476. doi: 10.1136/bmj.e2476. BMJ. 2012. PMID: 22592847 Review. No abstract available.
Adenocarcinoma of the pancreas--past, present and future.
Lygidakis NJ, Jain S, Sacchi M, Vrachnos P. Lygidakis NJ, et al. Hepatogastroenterology. 2005 Jul-Aug;52(64):1281-92. Hepatogastroenterology. 2005. PMID: 16001679 Review.
[Carcinoma of the pancreas--the palliative therapeutic possibilities outside of a radical surgical operation].
Rougier F, Marinov V. Rougier F, et al. Khirurgiia (Sofiia). 1991;44(2):69-75. Khirurgiia (Sofiia). 1991. PMID: 1716715 Review. Bulgarian. No abstract available.
[Serum tumor markers at exocrine adenocarcinoma of pancreas].
Holubec L, Finek J, Topolcan O, Svobodová S. Holubec L, et al. Cas Lek Cesk. 2005;144(2):86-8; discussion 89. Cas Lek Cesk. 2005. PMID: 15807292 Review. Czech.

See all similar articles

Cited by

Quality Assurance in Endoscopy: Which Parameters?
Denzer UW. Denzer UW. Visc Med. 2016 Feb;32(1):42-51. doi: 10.1159/000443653. Epub 2016 Jan 29. Visc Med. 2016. PMID: 27588295 Free PMC article. Review.
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.
Roeder F, Timke C, Saleh-Ebrahimi L, Schneider L, Hackert T, Hartwig W, Kopp-Schneider A, Hensley FW, Buechler MW, Debus J, Huber PE, Werner J. Roeder F, et al. BMC Cancer. 2012 Mar 23;12:112. doi: 10.1186/1471-2407-12-112. BMC Cancer. 2012. PMID: 22443802 Free PMC article. Clinical Trial.
[Prevention of gastrointestinal malignancies].
Hoffmeister A, Schiefke I, Teich N, Mössner J, Schoppmeyer K. Hoffmeister A, et al. Internist (Berl). 2008 Feb;49(2):178-84. doi: 10.1007/s00108-007-1998-3. Internist (Berl). 2008. PMID: 18210023 German.
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.
Kullmann F, Hollerbach S, Dollinger MM, Harder J, Fuchs M, Messmann H, Trojan J, Gäbele E, Hinke A, Hollerbach C, Endlicher E. Kullmann F, et al. Br J Cancer. 2009 Apr 7;100(7):1032-6. doi: 10.1038/sj.bjc.6604983. Epub 2009 Mar 17. Br J Cancer. 2009. PMID: 19293797 Free PMC article. Clinical Trial.
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2.
Märten A, Schmidt J, Ose J, Harig S, Abel U, Münter MW, Jäger D, Friess H, Mayerle J, Adler G, Seufferlein T, Gress T, Schmid R, Büchler MW. Märten A, et al. BMC Cancer. 2009 May 26;9:160. doi: 10.1186/1471-2407-9-160. BMC Cancer. 2009. PMID: 19470159 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York
Medical
- MedlinePlus Health Information